Sitaxsentan: an endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension
Author:
Publisher
Hindawi Limited
Subject
General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1368-5031.2006.00886.x/fullpdf
Reference63 articles.
1. Diagnosis and differential assessment of pulmonary arterial hypertension;Barst;J Am Coll Cardiol,2004
2. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry;D’Alonzo;Ann Intern Med,1991
3. Primary pulmonary hypertension;Rubin;N Engl J Med,1997
4. Clinical classification of pulmonary hypertension;Simonneau;J Am Coll Cardiol,2004
5. High dose calcium channel blocking therapy for primary pulmonary hypertension: evidence for long term reduction in pulmonary artery pressure and regression of right ventricular hypertrophy;Rich;Circulation,1987
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparative efficacy and acceptability of endothelin receptor antagonists for pulmonary arterial hypertension: A network meta-analysis;International Journal of Cardiology;2017-05
2. The ‘Connective Tissue Diseases’;Rook's Textbook of Dermatology;2010-05-06
3. Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension;European Respiratory Journal;2009-08-31
4. Endothelin-A Receptor Inhibition After Cardiopulmonary Bypass: Cytokines and Receptor Activation;The Annals of Thoracic Surgery;2008-11
5. Control of pulmonary vascular tone during exercise in health and pulmonary hypertension;Pharmacology & Therapeutics;2008-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3